Skip to main content
logo
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
101.88
-2.11 (-2.03%)
At close: Mar 30, 2026, 4:00 PM EDT
102.74
+0.86 (0.84%)
Pre-market: Mar 31, 2026, 7:24 AM EDT

Abbott Laboratories Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Medical Devices
21.39B20.76B20.06B19.43B18.99B18.38B17.88B17.44B
Medical Devices Growth
12.65%12.99%12.22%11.40%12.43%13.48%14.90%16.10%
Diagnostics
8.94B9.00B9.16B9.18B9.34B9.36B9.39B9.51B
Diagnostics Growth
-4.33%-3.79%-2.48%-3.50%-6.48%-13.05%-21.61%-31.97%
Nutrition
8.45B8.64B8.55B8.49B8.41B8.32B8.33B8.26B
Nutrition Growth
0.45%3.82%2.69%2.86%3.18%4.90%8.80%9.60%
Established Pharmaceuticals
5.54B5.42B5.32B5.23B5.19B5.15B5.11B5.10B
Established Pharmaceuticals Growth
6.58%5.32%4.05%2.45%2.53%1.74%1.83%3.01%
Other
17.00M17.00M17.00M16.00M16.00M15.00M15.00M14.00M
Other Growth
6.25%13.33%13.33%14.29%14.29%15.38%25.00%27.27%

Revenue by Geography

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
International
27.20B26.76B26.12B25.70B25.63B25.29B25.18B24.96B
International Growth
6.15%5.83%3.75%2.98%3.93%4.33%3.93%2.40%
United States
17.13B17.08B16.99B16.65B16.32B15.93B15.55B15.37B
United States Growth
4.92%7.24%9.27%8.30%5.64%1.33%-2.83%-10.29%

Operating Expense Breakdown

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Selling, General, and Administrative
12.33B12.11B11.95B11.80B11.70B11.51B11.34B11.15B
Selling, General, and Administrative Growth
5.43%5.18%5.40%5.86%6.83%2.82%1.21%-0.69%
Research and Development
2.94B2.96B2.90B2.88B2.84B2.80B2.75B2.77B
Research and Development Growth
3.45%5.76%5.41%3.79%3.76%1.05%-4.24%-2.60%
Amortization
1.68B1.73B1.78B1.83B1.88B1.89B1.92B1.95B
Amortization Growth
-10.44%-8.92%-7.55%-6.21%-4.48%-4.39%-3.18%-2.26%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.